✦ LIBER ✦

Anti-idiotypic monoclonal antibody cancer vaccines

✍ Scribed by Paul B. Chapman

Book ID: 113408918
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 727 KB
Volume: 6
Category: Article
ISSN: 1044-579X
DOI: 10.1016/1044-579x(95)90006-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-ganglioside anti-idiotypic monoclon

Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma

✍ Y. Diaz; A. Gonzalez; A. Lopez; R. Perez; A. M. Vazquez; E. Montero 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 557 KB

Monoclonal antibodies specific for human

Monoclonal antibodies specific for human colon carcinoma; associated antigens; monoclonal antibody production, chimeric antibody engineering and anti-idiotype antibody production for use in cancer therapy and vaccine : Tsang KY World 9608 514; 21 March 1996

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Assays to detect monoclonal anti-idiotyp

Assays to detect monoclonal anti-idiotypic anti-idiotypic antibodies

✍ Norman Mermelstein; Grant Morahan 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Anti-idiotypic antibodies as immunogens:

Anti-idiotypic antibodies as immunogens: idiotype-based vaccines

✍ A.G. Dalgleish; R.C. Kennedy 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 627 KB

Humoral anti-idiotypic and anti-anti-idi

Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A

✍ Jan Fagerberg; Peter Ragnhammar; Maria Liljefors; Anna-Lena Hjelm; Håkan Mellste 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 137 KB

Disialoganglioside GD2 anti-idiotypic mo

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies

✍ Nai-Kong V. Cheung; Adela Canete; Irene Y. Cheung; Jian-Nan Ye; Chongyuan Liu 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 788 KB

Disialoganglioside GD2 is widely expressed among neuroblastomas, melanomas, small-cell lung carcinoma, sarcomas and brain tumors. Immunity directed against this antigen may have anti-tumor utility. Since GDz is poorly immunogenic, antiidiotypic antibodies may serve as alternative tumor vaccines. Mon